SARS-CoV-2 post-infective myocarditis: the tip of COVID-19 immune complications?

Pierre Tissières; Jean-Louis Teboul

doi:10.1186/s13613-020-00717-0

SARS-CoV-2 post-infective myocarditis: the tip of COVID-19 immune complications?

Ann Intensive Care. 2020 Jul 23;10(1):98. doi: 10.1186/s13613-020-00717-0.

Authors

Pierre Tissières^{1

2}, Jean-Louis Teboul³

Affiliations

¹ Pediatric Intensive Care, AP-HP Paris Saclay University, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France. pierre.tissieres@aphp.fr.
² Institute of Integrative Biology of the Cell, CNRS, CEA, Univ. Paris Saclay, Gif-sur-Yvette, France. pierre.tissieres@aphp.fr.
³ Medical Intensive Care, AP-HP Paris Saclay University, Bicêtre Hospital, Le Kremlin-Bicêtre, France.

Abstract

Recent paediatric cases of acute myocarditis following a SARS-CoV-2 infection have raised the possibility of post-infective complications of COVID-19. This short editorial is reviewing current understanding of this new complication, its pathophysiology, diagnosis and therapeutic strategy.

Keywords: COVID-19; Kawasaki disease; MIS-C; Myocarditis; Post-infective complications; SARS-CoV-2.

Publication types

Review